Global Health Innovative Technology Fund (GHIT Fund)
The Global Health Innovative Technology Fund (GHIT Fund) is an international public-private partnership between the Government of Japan, multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme (UNDP). It facilitates global R&D partnerships for the discovery and development of new health technologies for the developing world and invests in these global R&D partnerships through a grant-making mechanism. Its portfolio covers drugs, vaccines, and diagnostics in infectious diseases, such as HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases.
GHIT Fund publishes calls for proposals under four platforms:
Please see below for more information about open opportunities.
There is currently one funding opportunity available under the Screening Platform: GHIT Fund RFP Screening Programme 2024-001.
- GHIT Fund RFP Screening Programme 2024-001:
- Closing date: 05 July 2024
Please refer to the GHIT Investment Opportunity schedule for the anticipated future call for proposals. A number of calls are foreseen for:
- Target Research:
-
- 2 RFPs are (tentatively) expected relating to drugs, vaccines, diagnostics in the area of Malaria, TB, selected NTDs
-
- Screening Platform:
-
- 2 RFPs are expected relating to drugs in the areas of Malaria, TB, Chagas disease, Visceral leishmaniasi
-
- Hit-to-Lead Platform:
-
- 2 RFPs are expected relating to drugs in the areas of Malaria, TB, Chagas disease, Visceral leishmaniasi
-
- Product Development Platform:
-
- 2 RFPs are (tentatively) expected relating to drugs, vaccines, diagnostics in the area of Malaria, TB, selected NTDs
-
Depending on the specific opportunity
For further information about eligibility criteria for GHIT Fund RFP Screening Programme 2024-001, please refer to the GHIT RFP Screening Platform 2024-001 Contact Form.
For further information about GHIT Fund’s data and product access policies, please click here.
Depending on the specific opportunity
For further information about the GHIT Fund RFP Screening Platform 2024, click here. Please note that questions specific to GHIT Fund RFP Screening Platform 2024-001 can only be answered with the submission of the GHIT RFP Screening Platform 2024-001 Contact Form.
For further information about general partnerships with GHIT Fund, email info@ghitfund.org. For further information about R&D partnerships, please email grants@ghitfund.org.